Jove
Visualize
Contact Us

Related Experiment Videos

Prostaglandins and obesity.

P B Curtis-Prior

    Lancet (London, England)
    |April 19, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Metabolic obesity hinders energy release from fat stores due to restrained lipolysis. Overproduction of prostaglandins may disrupt this process, suggesting potential therapeutic targets.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Computerized methods of neuropsychological assessment.

    British journal of hospital medicine·1996
    Same author

    Polyphloretin phosphate (PPP) antagonists of prostaglandin action also inhibit prostaglandin biosynthesis in-vitro.

    The Journal of pharmacy and pharmacology·1990
    Same author

    Comparative effects of (+)-propranolol and nonoxynol-9 on human sperm motility in-vitro.

    The Journal of pharmacy and pharmacology·1990
    Same author

    Beta-adrenoceptor antagonists and human sperm motility.

    The Journal of pharmacy and pharmacology·1990
    Same author

    The relaxant and spasmogenic effects of some xanthine derivatives acting on guinea-pig isolated trachealis muscle.

    British journal of pharmacology·1988
    Same author

    A modified transmembrane migration method for evaluating the spermicidal potency of some nonoxynol compounds.

    The Journal of pharmacy and pharmacology·1988
    Same journal

    Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

    Lancet (London, England)·2026
    Same journal

    Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

    Lancet (London, England)·2026
    Same journal

    Inherited retinal degenerations: clinical phenotypes and emerging therapies.

    Lancet (London, England)·2026
    Same journal

    Documenting hospice care.

    Lancet (London, England)·2026
    Same journal

    After the wood chipper.

    Lancet (London, England)·2026
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Biochemistry
    • Metabolic Disorders
    • Endocrinology

    Background:

    • Metabolic obesity is characterized by inaccessible energy in triglyceride stores.
    • Lipolysis, the process of freeing fatty acids and glycerol, appears restrained in metabolic obesity.
    • A balance normally exists between lipolysis-promoting reactions and prostaglandin-mediated negative feedback.

    Purpose of the Study:

    • To investigate the potential role of prostaglandins in the impaired lipolysis observed in metabolic obesity.
    • To explore the biochemical mechanisms underlying energy accessibility in metabolic obesity.

    Main Methods:

    • The study proposes a hypothesis based on existing knowledge of lipolysis and prostaglandin function.
    • It does not detail specific experimental methods but focuses on a theoretical biochemical error.

    Related Experiment Videos

    Main Results:

    • A biochemical error leading to prostaglandin overproduction is hypothesized as the cause of restrained lipolysis.
    • This overproduction may overwhelm the forward lipolytic reaction, preventing fat breakdown.

    Conclusions:

    • The hypothesis suggests that metabolic obesity involves an imbalance in the lipolytic pathway due to excessive prostaglandins.
    • The existence of prostaglandin antagonists and synthesis inhibitors presents potential therapeutic avenues for managing metabolic obesity.